Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001250853-18-000145
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-04 19:00:26
Reporting Period:
2018-12-03
Accepted Time:
2018-12-04 19:00:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561743 Kindred Biosciences Inc. KIN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337252 Richard Chin C/o Kindred Biosciences, Inc.
1555 Bayshore Highway, Suite 200
Burlingame CA 94010
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 40,000 $13.28 1,946,071 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 11, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.68, inclusive.